+ More
Technology
Collaborations
 News Room
 Contact Us
Home \ + More \ Collaborations 

Advancing Science Through Collaborations

In addition to private investment, GlySens’s substantial record of early support through peer-reviewed targeted research awards demonstrates a solid foundation of program validation.  Funding agencies, programs, and collaborative partners that have participated in our research and development program include:

National Institutes for Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

The National Institutes of Health is the United States’ medical research agency–supporting scientific studies that turn discovery into health.  NIH is the largest source of funding for medical research in the world, investing more than $31 billion annually in medical research for the American people.  The mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people’s health and quality of life.

Juvenile Diabetes Research Foundation (JDRF)

JDRF is a leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until a world without T1D exists. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D.

JDRF funded research has led to many landmark advances in T1D science. JDRF is in the exciting position to currently fund 50 human clinical trials. Since its inception, JDRF has contributed more than $2 billion to T1D research. JDRF’s efforts have significantly advanced the care of people with diabetes and have expanded the critical scientific understanding of T1D.

U.S. Army’s Technologies for Metabolic Monitoring (TMM) Program /
Department of Defense

The Technologies for Metabolic Monitoring (TMM) and Julia Weaver Fund (JWF) Research Program was a collaborative initiative between the U.S. Army Medical Research and Materiel Command (USAMRMC), the Juvenile Diabetes Research Foundation (JDRF), National Aeronautical and Space Administration (NASA), and the National Institutes of Health (NIH, NIDDK). The overall program goal of the TMM and JWF Research Program was to fund scientifically meritorious research in accordance with directives received from Congress. 

National Institute of Standards and Technology’s Advanced Technology Program (NIST-ATP)

NIST is one of the nation’s oldest physical science laboratories and was established by Congress to remove impediments to U.S. industrial competitiveness.   NIST’s Advanced Technology Program (ATP) was created to spur the development of path-breaking new technologies by providing cost-shared funding for selected valuable R&D projects.  Today, NIST’s mission continues to promote U.S. innovation and industrial competitiveness by advancing measurement science, standards, and technology in ways that enhance economic security and improve quality of life.


University of California at San Diego (UCSD)

The University of California San Diego is an academic powerhouse and economic engine, recognized as 10th Best Public University by U.S. News and World Report (2017). The UCSD Jacobs School of Engineering ranks 7th overall, and first among all public engineering schools, for research expenditures per faculty member by U.S. News, (2017). This reflects UC San Diego's leadership as a research university with researchers consistently earning international acclaim. They include Nobel and Pulitzer prize winners, members of the National Academies, and recipients of MacArthur Foundation “genius grants.”
Certain of the research reported on this website was supported under various awards from the above-named entities.  The content presented herein is solely the responsibility of GlySens Incorporated and does not necessarily represent the official views of these entities.
3931 Sorrento Valley Blvd
Suite 110
San Diego, CA 92121
Ph:  +1 (858) 638-7708
Fax: +1 (858) 638-7727

TechnologyNews RoomCareersContact Us

© 2017 GlySens Incorporated. All Rights Reserved.
Caution - INVESTIGATIONAL DEVICE, LIMITED BY FEDERAL LAW TO INVESTIGATIONAL USE.
GlySens®, Eclipse®, and ICGM® are trademarks of GlySens Incorporated registered in the U.S. Patent and Trademark Office.
 Terms of Use Privacy Policy
map-markercogsphonelinkedinslidesharenewspaper-omenu